DRQ-38041-47271
4 vaccinations
3 coded responses
13 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 614 / IL
- Registered
- 2022-04-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-09
Dose 1 — Moderna
-
2021-04-08
Dose 2 — Moderna
-
2021-11-18
Dose 3 — Moderna
-
2022-04-13
Dose 4 — Moderna
-
2022-04-14
Registered in v-safe
-
2022-04-14
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Muscle or body aches, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-15
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-04-16
-
2022-04-17
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-18
Survey response — days 1–6 daily, dose 4MedDRA: Injection site bruising — Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessFree text: Bruise at injection siteMedDRA releases: 2024-11 · check-in free text available
- 2022-04-22
- 2022-04-27
- 2022-05-06
- 2022-05-18
- 2022-05-26
-
2022-07-15
Survey response — 3 months, dose 4MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVID on June 18MedDRA releases: 2024-11 · check-in free text available
-
2022-07-15
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-07-18
- 2022-10-12
-
2023-04-13
Survey response — 12 months, dose 4MedDRA: Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-13
Report sent to call center — 12 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-04-14
- 2023-04-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-09 | Moderna | No |
| 2 | 2021-04-08 | Moderna | No |
| 3 | 2021-11-18 | Moderna | No |
| 4 | 2022-04-13 | Moderna | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Bruise at injection site
Release 12 — 3 months, dose 4
Symptoms: COVID on June 18
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Injection site bruising | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release